FrancophonIA/ELRC3.0 huggingface dataset:
English: The European Medicines Agency has waived the obligation to submit the results of studies with the reference medicinal product containing infliximab in all subsets of the paediatric population in rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis and Crohn's disease (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med referencelægemidlet, som indeholder infliximab i alle undergrupper af den pædiatriske population med reumatoid arthritis, juvenil idiopatisk arthritis, psoriasis arthritis, ankyloserende spondylitis, psoriasis og Crohns sygdom (se pkt.
English: Among patients in the infliximab 5 mg/kg group who crossed over because of loss of fistula response after week 22, 57% (12/21) responded to re-treatment with infliximab 10 mg/kg every 8 weeks.
Danish: Blandt patienter i infliximab-gruppen 5 mg/kg, der krydsede over på grund af tab af fistel respons efter uge 22, responderede 57% (12/21) på genbehandling med infliximab 10 mg/kg hver 8. uge.
English: 3 mg/kg 6 mg/kg Combined
Danish: 6 mg/kg Kombineret
English: • Signs of a nervous system problem (including eye problems) such as signs of a stroke (sudden numbness or weakness of your face, arm or leg, especially on one side of your body; sudden confusion, trouble speaking or understanding; trouble seeing in one or both eyes, trouble walking, dizziness, loss of balance or coordination or a severe headache), fits, tingling/numbness in any part of your body, or weakness in arms or legs, changes in eyesight such as double vision or other eye problems.
Danish: • Tegn på et problem i nervesystemet (inklusive øjenproblemer) såsom tegn på slagtilfælde (pludselig følelsesløshed eller svaghed i ansigt, arme eller ben, særligt i den ene side af kroppen; pludselig forvirring, besvær med at tale eller forstå; besvær med at se med det ene eller begge øjne, gangbesvær, svimmelhed, tab af balance- eller koordinationsevne eller svær hovedpine), krampeanfald, prikken/følelsesløshed et sted i kroppen eller svaghed i arme eller ben, ændringer i synet såsom dobbeltsyn eller andre øjenproblemer.
English: • Tell your doctor if you have an infection even if it is a very minor one.
Danish: • Fortæl din læge, hvis du har en infektion, også selvom det er en meget let infektion
English: Antibodies to infliximab developed in 38% of patients receiving 3 mg/kg compared with 12% of patients receiving 6 mg/kg.
Danish: Der udvikledes infliximab-antistoffer hos 38% af patienterne, som fik 3 mg/kg sammenlignet med 12% af patienterne, som fik 6 mg/kg.
English: In an exploratory clinical study evaluating the use of infliximab in patients with moderate to severe chronic obstructive pulmonary disease (COPD), more malignancies were reported in infliximab-treated patients compared with control patients.
Danish: I et uddybende klinisk studie, der vurderede anvendelsen af infliximab hos patienter med moderat til svær kronisk obstruktiv lungesygdom (KOL), blev der rapporteret flere maligne sygdomme hos patienter behandlet med infliximab sammenlignet med kontrolpatienter.
English: The efficacy of infliximab was assessed in two multicentre, randomised, double-blind, pivotal clinical studies: ATTRACT and ASPIRE.
Danish: Virkningen af infliximab blev vurderet i to multicenter, randomiserede, dobbeltblindede, basale kliniske studier: ATTRACT og ASPIRE.
English: • This medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 °C for a single period of up to six months, but not beyond the original expiry date.
Danish: • Lægemidlet kan også opbevares i den originale pakning uden for køleskab ved højst 25°C i en enkelt periode på op til 6 måneder, men den oprindelige udløbsdato må ikke overskrides.
English: • Possible signs of cancer including but not limited to swelling of lymph nodes, weight loss, fever, unusual skin nodules, changes in moles or skin colouring, or unusual vaginal bleeding.
Danish: • Mulige tegn på kræft inklusive, men ikke begrænset til, hævede lymfeknuder, vægttab, feber, usædvanlige knuder i huden, ændringer i modermærker eller hudfarven eller usædvanlig blødning fra skeden.
English: The dose and the number of Inflectra vials have to be calculated.
Danish: Dosis og antal af de nødvendige Inflectra-hætteglas beregnes.
English: If active tuberculosis is diagnosed, infliximab therapy must not be initiated (see section 4.3).
Danish: Ved aktiv tuberkulose, må infliximab-behandling ikke påbegyndes (se pkt.
English: Available data do not support further infliximab treatment, in patients not responding within 6 weeks of the initial infusion.
Danish: Foreliggende data støtter ikke fortsat infliximab-behandling hos patienter, der ikke responderer inden for 6 uger efter den første infusion.
English: • Tell your doctor if you have any abnormal skin openings (fistulae) before you are given Inflectra.
Danish: • Fortæl din læge, hvis du har nogen unormale hudåbninger (fistler), før du får Inflectra.
English: In this trial, sixty-six percent of the patients (686 out of 1,040) received at least one shortened infusion of 90 minutes or less and 44% of the patients (454 out of 1,040) received at least one shortened infusion of 60 minutes or less.
Danish: I dette studie fik 66% af patienterne (686 ud af 1.040) mindst én kort infusion på 90 minutter eller mindre.
English: The overall incidence of infections in C0168T72 was 13/22 (59%) in the every 8 week maintenance treatment group and 14/23 (60.9%) in the every 12 week maintenance treatment group.
Danish: Den samlede forekomst af infektioner i C0168T72 var 13/22 (59%) i 8-ugers vedligeholdelsesbehandlingsgruppen og 14/23 (60,9%) i 12-ugers vedligeholdelsesbehandlingsgruppen.
English: • Treatment with TNF blockers such as Inflectra may result in reactivation of hepatitis B virus in patients who carry this virus, which can be life-threatening in some cases.
Danish: • Behandling med TNF-blokkere, såsom Inflectra, kan medføre, at hepatitis B igen bliver aktiv hos patienter, som bærer denne virus.
English: Efficacy and safety were assessed in two multicentre, double-blind, placebo-controlled studies in patients with active psoriatic arthritis.
Danish: Virkning og sikkerhed blev vurderet i to dobbeltblindede, placebokontrollerede multicenterstudier hos patienter med aktiv psoriasis arthritis.
English: • Some patients receiving infliximab have developed serious liver problems.
Danish: • Nogle patienter, som får infliximab, har udviklet alvorlige leverproblemer.
English: Transverse myelitis, central nervous system demyelinating disorders (multiple sclerosis-like disease and optic neuritis), peripheral demyelinating disorders (such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy).
Danish: Transvers myelitis, demyeliniseringssygdomme i centralnervesystemet (dissemineret sklerose-lignende sygdom og optisk neuritis), perifere demyeliniseringssygdomme (såsom Guillain-Barré syndrom, kronisk inflammatorisk demyeliniserende polyneuropati og multifokal motorisk neuropati).
English: Inflectra should be administered intravenously.
Danish: Inflectra administreres intravenøst.
English: Sodium dihydrogen phosphate monohydrate Disodium phosphate dihydrate
Danish: Natriumdihydrogen-phosphatmonohydrat Dinatriumphosphatdihydrat
English: In SPIRIT, the proportion of patients achieving PASI 75 at week 10 was 71.7% in the 3 mg/kg infliximab group, 87.9% in the 5 mg/kg infliximab group, and 5.9% in the placebo group (p<0.001).
Danish: I SPIRIT var andelen af patienter, der opnåede PASI 75 i uge 10 71,7% i 3 mg/kg infliximab-gruppen, 87,9% i 5 mg/kg infliximab-gruppen og 5,9% i placebogruppen (p < 0,001).
English: For women taking Inflectra including those over 60 years of age, your doctor may recommend regular screening for cervical cancer.
Danish: Lægen kan tilråde, at kvinder, der får Inflectra, herunder kvinder over 60 år, regelmæssigt screenes for livmoderhalskræft.
English: Tuberculosis, fungal infections (e.g. candidiasis, onychomycosis).
Danish: Tuberkulose, svampeinfektioner (fx candidiasis, onykomykose).
English: Some of these infections have been fatal; the most frequently reported opportunistic infections with a mortality rate of > 5% include pneumocystosis, candidiasis, listeriosis and aspergillosis (see section 4.4).
Danish: Nogle af disse infektioner har været letale; de opportunistiske infektioner, der oftest er set med en mortalitetsrate > 5%, indbefatter pneumocystose, candidiasis, listeriose og aspergillose (se pkt.
English: Infections were reported more frequently for subjects who received q8 week as opposed to q12 week infusions (73.6% and 38.0%, respectively), while serious infections were reported for 3 subjects in the q8 week and 4 subjects in the q12 week maintenance treatment group.
Danish: Der blev rapporteret infektioner oftere hos personer som fik infusioner hver 8. uge i forhold til hver 12. uge (hhv. 73,6% og 38,0%), mens der blev rapporteret alvorlige infektioner hos 3 personer i 8 ugers gruppen og 4 personer i 12 ugers vedligeholdelsesbehandlingsgruppen.
English: How much Inflectra is given
Danish: Hvor meget Inflectra får du
English: Upon removal from refrigerated storage, Inflectra must not be returned to refrigerated storage.
Danish: Når Inflectra er taget ud af køleskabet, må det ikke sættes tilbage på køl igen.
English: At week 54, the figures were 55.8% (29/52) and 23.5% (12/51) in the q8 weeks and q12 weeks maintenance groups, respectively (p < 0.001).
Danish: I uge 54 var tallene 55,8% (29/52) og 23,5% (12/51) for henholdsvis 8-ugers gruppen og 12-ugers gruppen (p < 0,001).
English: If you were using Inflectra during pregnancy, tell your baby's doctor and other healthcare professionals caring for your baby about your Inflectra use before the baby receives any vaccines.
Danish: Hvis De har fået Inflectra, mens De var gravid, skal De fortælle Deres barns læge og andet sundhedspersonale, der tager sig af Deres barn, at De har fået Inflectra, før barnet bliver vaccineret.
English: Inflectra may be stored at temperatures up to a maximum of 25 °C for a single period of up to 6 months, but not exceeding the original expiry date.
Danish: Inflectra kan opbevares ved temperaturer på op til højst 25°C i en enkelt periode på op til 6 måneder, men den oprindelige udløbsdato må ikke overskrides.
English: Induction treatment in fistulising active Crohn's disease The efficacy was assessed in a randomised, double-blinded, placebo-controlled study in 94 patients with fistulising Crohn's disease who had fistulae that were of at least 3 months' duration.
Danish: Induktionsbehandling af fistulerende, aktiv Crohns sygdom Virkningen blev også vurderet i et randomiseret, dobbeltblindet, placebokontrolleret studie hos 94 patienter med fistulerende Crohns sygdom, som havde fistler af mindst 3 måneders varighed.
English: In rheumatoid arthritis clinical studies, the incidence of serious infections was greater in infliximab plus methotrexate-treated patients 65 years and older (11.3%) than in those under 65 years of age (4.6%).
Danish: I kliniske studier af reumatoid arthritis var hyppigheden af alvorlige infektioner højere hos infliximabplus methotrexatbehandlede patienter på 65 år og derover (11,3%) sammenlignet med patienter under 65 år (4,6%).
English: If these medicines do not work well enough, you will be given Inflectra to treat your disease.
Danish: Hvis disse lægemidler ikke virker godt nok, vil du få Inflectra til behandling af din sygdom.
English: • The other ingredients are sucrose, polysorbate 80, sodium dihydrogen phosphate monohydrate and disodium phosphate dihydrate.
Danish: • Øvrige indholdsstoffer: saccharose, polysorbat 80, natriumdihydrogen-phosphatmonohydrat og dinatriumphosphatdihydrat.
English: (van der Heijde-modified Sharp score) Change from baseline (Mean ± SD c)
Danish: Total score d (van der Heijdemodified Sharp score) Ændring fra baseline (Gennemsnit ± SD
English: In the second clinical study (IMPACT 2), efficacy and safety of infliximab were studied in 200 patients with active psoriatic arthritis (≥ 5 swollen joints and ≥ 5 tender joints).
Danish: I det andet kliniske studie (IMPACT 2) blev virkning og sikkerhed af infliximab undersøgt hos 200 patienter med aktiv psoriasis arthritis (≥ 5 hævede led og ≥ 5 ømme led).
English: At week 12, the number of BASDAI 50 responders were 3/35 (9%) in the placebo group, and 20/35 (57%) in the 5 mg/kg group (p<0.01).
Danish: I uge 12 var antallet af BASDAI 50 respondere 3/35 (9%) i placebogruppen og 20/35 (57%) i 5 mg/kg gruppen (p < 0,01).
English: • Signs of serious skin problems such as reddish-target-like spots or circular patches often with central blisters on the trunk, large areas of peeling and shedding (exfoliating) skin, ulcers of mouth, throat, nose, genitals and eyes or small pus-filled bumps that can spread over the body.
Danish: • Tegn på alvorlige hudproblemer såsom rødlige, målskivelignende pletter eller runde områder ofte med blærer centralt på kroppen, store områder med afskalning af huden (eksfoliation), sår i mund, svælg, næse, kønsorganer og øjne eller små pusholdige blærer, som kan sprede sig over hele kroppen.
English: In patients with pre-existing or recent onset of demyelinating disorders, the benefits and risks of anti-TNF treatment should be carefully considered before initiation of infliximab therapy.
Danish: Hos patienter med allerede eksisterende eller nyligt opståede demyeliniseringssygdomme skal vurdering af forventet gavn og risiko ved anti-TNF-behandlingen overvejes omhyggeligt før initiering af behandling med infliximab.
English: EXPRESS Placebo → Infliximab 5 mg/kg (at week 24)
Danish: Placebo → Infliximab 5 mg/kg (i uge 24)
English: • Tell your doctor before you are given Inflectra if you have a lung disease called chronic obstructive pulmonary disease (COPD) or if you are a heavy smoker.
Danish: • Før du får Inflectra, skal du fortælle det til din læge, hvis du har en lungesygdom kaldet kronisk obstruktiv lungesygdom (KOL, rygerlunger), eller hvis du er storryger.
English: It is recommended that the conduct of these tests should be recorded in the patient's reminder card. Prescribers are reminded of the risk of false negative tuberculin skin test results, especially in patients who are severely ill or immunocompromised.
Danish: Opmærksomheden henledes på risikoen for falsk negative resultater af tuberkulintesten, især hos patienter, der er alvorligt syge eller immunsupprimerede.
English: Induction treatment in moderately to severely active Crohn's disease The efficacy of a single dose treatment with infliximab was assessed in 108 patients with active Crohn's disease (Crohn's Disease Activity Index (CDAI) ≥ 220 ≤ 400) in a randomised, double-blinded, placebo-controlled, dose-response study.
Danish: Induktionsbehandling af moderat til svært aktiv Crohns sygdom Virkningen af en éndosis behandling med infliximab blev vurderet hos 108 patienter med aktiv Crohns sygdom (Crohn's Disease Activity Index (CDAI) ≥ 220 ≤ 400) i et randomiseret, dobbeltblindet, placebokontrolleret, dosis-virknings studie.
English: Can be stored at room temperature (up to 25 °C) for a single period up to 6 months, but not exceeding the original expiry date.
Danish: Kan opbevares ved almindelig temperatur (op til 25°C) i en enkelt periode på op til 6 måneder, men den oprindelige udløbsdato må ikke overskrides.
English: The most serious ADRs associated with the use of TNF blockers that have been reported for infliximab include HBV reactivation, CHF (congestive heart failure), serious infections (including sepsis, opportunistic infections and TB), serum sickness (delayed hypersensitivity reactions), haematologic reactions, systemic lupus erythematosus/lupus-like syndrome, demyelinating disorders, hepatobiliary events, lymphoma, HSTCL, leukaemia, Merkel cell carcinoma, melanoma, paediatric malignancy, sarcoidosis/sarcoid-like reaction, intestinal or perianal abscess (in Crohn's disease), and serious infusion reactions (see section 4.4).
Danish: De alvorligste bivirkninger forbundet med brugen af TNF-blokkere, som er blevet rapporteret for infliximab, inkluderer HBV-reaktivering, CHF (hjerteinsufficiens), alvorlige infektioner (inklusive sepsis, opportunistiske infektioner og TB), serumsygdom (forsinkede overfølsomhedsreaktioner), hæmatologiske reaktioner, systemisk lupus erythematosus/lupus-lignende syndrom, demyeliniserende sygdomme, hepatobiliære bivirkninger, lymfomer, HSTCL, leukæmi, Merkelcellekarcinom, melanom, pædiatrisk malignitet, sarkoidose/sarkoid-lignende reaktion, byld i tarmen eller ved endetarmen (ved Crohns sygdom) og alvorlige infusionsreaktioner (se pkt.
English: The primary endpoint was the proportion of patients who experienced a clinical response, defined as ≥ 50% reduction from baseline in the number of fistulae draining upon gentle compression on at least two consecutive visits (4 weeks apart), without an increase in the use of medicinal products or surgery for Crohn's disease.
Danish: Det primære endepunkt var andelen af patienter, der oplevede en klinisk virkning, bestemt som ≥ 50% reduktion fra baseline i antallet af fistler, drænet ved forsigtigt tryk, ved mindst to på hinanden følgende besøg (med 4 ugers mellemrum) uden øget brug af lægemidler eller kirurgisk indgreb for Crohns sygdom.
English: • These infections may be serious and include tuberculosis, infections caused by viruses, fungi, bacteria or other organisms in the environment and sepsis that may, be life-threatening.
Danish: • Disse infektioner kan være alvorlige og indbefatte tuberkulose, infektioner forårsaget af virus, svampe, bakterier eller andre organismer, der findes i miljøet (infektioner som kun fremkommer, hvis du er særligt disponeret) samt blodforgiftning, som kan være livstruende.
English: Inflectra and Orencia should not be used together.
Danish: Du må ikke få Inflectra og Orencia samtidig.
English: Efficacy and safety of infliximab were assessed in two multicentre, double-blind, placebo-controlled studies in patients with active ankylosing spondylitis (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] score ≥ 4 and spinal pain ≥ 4 on a scale of 1-10).
Danish: Infliximabs virkning og sikkerhed blev undersøgt i to multicenter, dobbelblindede, placebokontrollerede studier hos patienter med aktiv ankyloserende spondylitis (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] score≥ 4 og spinalsmerte ≥ 4 på en skala på 1-10)
English: At week 30, the proportion of subjects in clinical remission was higher in the q8 week (59.6%, 31/52) than the q12 week maintenance treatment group (35.3%, 18/51; p=0.013).
Danish: I uge 30 var andelen af personer med klinisk remission højere i 8-ugers gruppen (59,6%; 31/52) end i 12-ugers gruppen (35,3%, 18/51; p=0,013).
English: Anti-dsDNA antibodies were newly detected in approximately 17% of infliximab-treated patients compared with 0% of placebo-treated patients.
Danish: Anti-dsDNA antistoffer blev påvist første gang hos cirka 17% af infliximab-behandlede patienter sammenlignet med 0% af placebobehandlede patienter.
English: Store at 2 °C - 8 °C.
Danish: Opbevares ved 2°C - 8°C.
English: The concurrent administration of live vaccines with infliximab is not recommended.
Danish: Samtidig administration af levende vacciner og infliximab frarådes.
English: Patients received 3 or 6 mg/kg infliximab as a 3-dose induction regimen (weeks 0, 2, 6 or weeks 14, 16, 20, respectively) followed by maintenance therapy every 8 weeks, in combination with methotrexate.
Danish: Patienterne fik 3 eller 6 mg/kg infliximab som et 3 dosis induktionsregi (hhv. uge 0, 2, 6 eller uge 14, 16, 20) fulgt af vedligeholdelsesbehandling hver 8. uge i kombination med methotrexat.
English: In clinical studies concurrent administration of TNF-antagonists and abatacept has been associated with an increased risk of infections including serious infections compared to TNF-antagonists alone, without increased clinical benefit.
Danish: Samtidig administration af TNF-alfahæmmere og abatacept har i kliniske studier været forbundet med en øget risiko for infektioner, inklusive alvorlige infektioner, uden en øget klinisk fordel, sammenlignet med TNF-hæmmere alene.
English: Table 5 Effects on response and remission rate, data from ACCENT I (Week-2 responders) ACCENT I (Week-2 responders) % of Patients
Danish: Tabel 5 Virkninger på respons og remissionshastighed, data fra ACCENT I (uge-2 responderende)
English: Maintenance treatment in moderately to severely active Crohn's disease in adults The efficacy of repeated infusions with infliximab was studied in a 1-year clinical study (ACCENT I).
Danish: Vedligeholdelsesbehandling af moderat til svært aktiv Crohns sygdom hos voksne Virkningen af gentagne infusioner med infliximab blev undersøgt i et 1-års klinisk studie (ACCENT I).
English: Caution should be exercised when considering TNF-blocking therapy for patients with a history of malignancy or when considering continuing treatment in patients who develop a malignancy.
Danish: Når TNF-blokerende behandling overvejes, bør forsigtighed udvises hos patienter med en fortid med maligne sygdomme, eller når fortsat behandling overvejes hos patienter, der udvikler maligne sygdomme.
English: Infliximab Maintenance (5 mg/kg) (n=96)
Danish: Infliximab Vedligeholdelse (5 mg/kg) (n=96)
English: During treatment with Inflectra
Danish: Under behandling med Inflectra
English: The side effects that happened more in children were: low red blood cells (anaemia), blood in stool, low overall levels of white blood cells (leukopenia), redness or blushing (flushing), viral infections, low levels of white blood cells that fight infection (neutropenia), bone fracture, bacterial infection and allergic reactions of the breathing tract.
Danish: Følgende bivirkninger forekom hyppigere hos børn: nedsat antal røde blodlegemer (anæmi), blod i afføringen, generelt nedsat antal hvide blodlegemer (leukopeni), anfaldsvis ansigtsrødme, virussinfektioner, lavt antal hvide blodlegemer, der bekæmper infektion (neutropeni), knoglebrud, bakterieinfektion og allergiske reaktioner i luftvejene.
English: Available data do not support further infliximab treatment in children and adolescents not responding within the first 10 weeks of treatment (see section 5.1).
Danish: De foreliggende data understøtter ikke yderligere infliximab-behandling af børn og unge, som ikke responderer inden for de første 10 ugers behandling (se pkt.
English: Continued therapy should be carefully reconsidered in patients who show no evidence of therapeutic benefit within the first 12 weeks of treatment or after dose adjustment.
Danish: Fortsat behandling bør revurderes nøje hos patienter, som ikke viser tegn på klinisk fordel inden for de første 12 ugers behandling eller efter dosisjustering.
English: The required volume of the reconstituted Inflectra solution should be diluted to 250 mL with sodium chloride 9 mg/mL (0.9%) solution for infusion.
Danish: Det påkrævede volumen af den rekonstituerede Inflectra-opløsning fortyndes til 250 ml med natriumchlorid 9 mg/ml (0,9%) infusionsvæske.
English: Inflectra is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including ciclosporin, methotrexate or psoralen ultra-violet A (PUVA) (see section 5.1).
Danish: Inflectra er indiceret til behandling af moderat til svær plaque psoriasis hos voksne patienter, som ikke responderede på, eller som har en kontraindikation for eller som ikke tåler anden systemisk behandling inklusive ciclosporin, methotrexat eller psoralen ultra-violet A (PUVA) (se pkt.
English: Immunogenicity Antibodies to infliximab were detected in 3 (2.9%) paediatric patients.
Danish: Immunogenicitet Der blev påvist antistoffer overfor infliximab hos 3 (2,9%) af børnene.
English: • treat active Crohn's disease,
Danish: • behandle aktiv Crohns sygdom
English: If these medicines do not work well enough, you will be given Inflectra to:
Danish: Hvis disse lægemidler ikke virker godt nok, vil du få Inflectra for at: